But, when a product is in shortage, licensed pharmacies and FDA-registered compounding facilities are permitted to manufacture versions of the FDA-approved product that are essentially a copy of the FDA-approved product until the shortage is resolved
The Journal of clinical endocrinology and metabolism
GLP-1 therapies remain expensive, and insurance coverage varies
A warm compress or an over-the-counter pain reliever (if safe for you) might ease the discomfort
Affected individuals are typically characterised by lipoatrophic diabetes, insulin resistance and hepatic steatosis ( Agonists of the glucagon-like peptide-1 receptor (GLP-1R) deliver significant beneficial effects both in treating type 2 diabetes and obesity ( Reports of the effects of GLP-1R agonists in individuals with inherited lipodystrophies are currently limited to only 3 case studies, and these examine FPLD but not CGL patients ( Here we used a well validated Bscl2 -null (seipin knockout) mouse model of CGL type 2 (CGL2) to examine the effectiveness of a GLP-1R agonist, in treating lipoatrophic diabetes, hepatic steatosis and hyperphagia in CGL to inform the adoption of this class of drugs for individuals with lipodystrophy
The lawsuit seeks damages related to death, funeral costs, and punitive damages